What Are the Advantages of Using Nanotechnology in Immune Checkpoint Inhibitors?
Several advantages make nanotechnology a compelling option for enhancing immune checkpoint inhibitors:
Targeted Delivery: Nanoparticles can be engineered to specifically target cancer cells, improving drug accumulation at the tumor site. Controlled Release: Nanocarriers can provide controlled and sustained release of drugs, enhancing their therapeutic effects. Reduced Toxicity: By targeting the drug more precisely, nanotechnology can reduce the side effects and toxicity associated with immune checkpoint inhibitors. Enhanced Stability: Nanoparticles can protect drugs from degradation, improving their stability and shelf-life.
